Similarly, it has been shown that compared with combination with anti-TGF or anti-IL-10R, combination with anti-CTLA-4 strikingly improves the therapeutic effect of VSV-mediated tumor regression by eliciting CD4+ and CD8+ T cells response [124]. This evidence concerns the gene CD4 and neoplasm.